Production (Stage)
Serina Therapeutics, Inc.
SER
$6.00
$0.254.35%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -50.99% | -51.80% | -57.99% | -30.48% | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 705.42% | -- | 13,590.79% | 18,334.21% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -35.62% | -25.50% | -28.61% | 2.06% | -- |
|
|
|||||
| Total Current Assets | -35.62% | -25.50% | -28.61% | 2.06% | -- |
| Net Property, Plant & Equipment | -24.56% | -22.31% | -6.10% | 19.83% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -38.00% | -25.02% | -15.40% | 9.95% | -- |
|
|
|||||
| Total Accounts Payable | -54.40% | 28.28% | 154.35% | 233.89% | -- |
| Total Accrued Expenses | -30.47% | 145.11% | 199.64% | 168.79% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -19.91% | -22.80% | -14.66% | -97.30% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -96.17% | -- |
| Total Other Current Liabilities | -- | -- | -- | -96.17% | -- |
| Total Current Liabilities | -83.27% | 67.45% | 876.16% | 47.21% | -- |
|
|
|||||
| Total Current Liabilities | -83.27% | 67.45% | 876.16% | 47.21% | -- |
| Long-Term Debt | -- | -- | -82.05% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -45.04% | -41.99% | -32.79% | -6.77% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 38,001.69% | 2,086.66% | -- |
| Total Liabilities | -65.90% | 27.95% | 271.21% | 182.79% | -- |
|
|
|||||
| Common Stock & APIC | 4,414.39% | 4,991.62% | 806.22% | 883.56% | -- |
| Retained Earnings | -803.97% | -33.58% | 36.38% | 35.56% | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 139.48% | 101.98% | 58.69% | 53.63% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 139.48% | 101.98% | 58.69% | 53.63% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 136.18% | -87.64% | -551.79% | -10,662.50% | -- |
|
|
|||||